Werewolf Therapeutics, Inc.
HOWL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785530
In the last 90 days, Werewolf Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 45 institutions reported holding it in 13F filings for Q2 2026, worth $3.91M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Werewolf Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 51
- +9 vs. Q3 2021
- Shares held
- 19.1M
- +132.8K (+0.7%) vs. Q3 2021
- Total value
- $228.3M
- −$98.0M (−30.0%) vs. Q3 2021
- New holders
- 12
- 21 more added
- Sold out
- 3
- 7 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HOWL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $3.91M |
| Q1 2026 | 48 | $11.7M |
| Q4 2025 | 51 | $9.34M |
| Q3 2025 | 62 | $41.6M |
| Q2 2025 | 65 | $24.3M |
| Q1 2025 | 70 | $26.7M |
| Q4 2024 | 73 | $41.7M |
| Q3 2024 | 69 | $68.3M |
| Q2 2024 | 71 | $79.2M |
| Q1 2024 | 61 | $209.0M |
| Q4 2023 | 41 | $106.8M |
| Q3 2023 | 35 | $51.1M |
| Q2 2023 | 36 | $73.3M |
| Q1 2023 | 38 | $62.5M |
| Q4 2022 | 39 | $42.8M |
| Q3 2022 | 44 | $94.5M |
| Q2 2022 | 46 | $78.0M |
| Q1 2022 | 49 | $83.5M |
| Q4 2021 | 51 | $228.3M |
| Q3 2021 | 42 | $326.2M |
| Q2 2021 | 45 | $344.3M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Werewolf Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Daiwa Securities Group Inc. | 80 | $1.00K | 0.00% | +80 | New |
| Confluence Wealth Services, Inc. | 100 | $1.00K | 0.00% | +100 | New |
| Financial Perspectives, Inc | 250 | $2.98K | 0.00% | 00.0% | Unchanged |
| High Net Worth Advisory Group LLC | 500 | $6.00K | 0.00% | +500 | New |
| Tower Research Capital LLC (TRC) | 652 | $8.00K | 0.00% | +234+56.0% | Added |
| STRS Ohio | 1,800 | $21.0K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 2,041 | $24.0K | 0.00% | +1,448+244.2% | Added |
| Legal & General Group Plc | 2,492 | $30.0K | 0.00% | +1,756+238.6% | Added |
| Royal Bank of Canada | 5,680 | $68.0K | 0.00% | +4,884+613.6% | Added |
| Citigroup Inc | 7,920 | $94.0K | 0.00% | +7,053+813.5% | Added |
| Morgan Stanley | 8,063 | $96.0K | 0.00% | +6,549+432.6% | Added |
| Metropolitan Life Insurance Co | 8,460 | $100.8K | 0.00% | +8,460 | New |
| UBS Group AG | 9,459 | $113.0K | 0.00% | +7,820+477.1% | Added |
| Goldman Sachs Group Inc | 10,080 | $120.0K | 0.00% | +10,080 | New |
| MetLife Investment Management | 11,421 | $136.0K | 0.00% | +11,421 | New |
| Susquehanna International Group, LLP | 11,829 | $141.0K | 0.00% | +11,829 | New |
| Wells Fargo & Company | 12,699 | $151.0K | 0.00% | +12,699 | New |
| Manufacturers Life Insurance Company, The | 12,831 | $153.0K | 0.00% | +12,831 | New |
| New York State Common Retirement Fund | 13,864 | $165.0K | 0.00% | −901−6.1% | Reduced |
| American International Group, Inc. | 14,034 | $167.0K | 0.00% | +9,891+238.7% | Added |
| California State Teachers Retirement System | 14,434 | $172.0K | 0.00% | +10,392+257.1% | Added |
| Granite Point Capital Management, L.P. | 15,000 | $179.0K | 0.07% | +15,000 | New |
| Deutsche Bank AG | 16,047 | $191.0K | 0.00% | +11,696+268.8% | Added |
| Rhumbline Advisers | 19,305 | $230.0K | 0.00% | +19,305 | New |
| Evercore Wealth Management, LLC | 21,500 | $256.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 22,034 | $262.0K | 0.00% | +22,034 | New |
| JPMorgan Chase & Co | 28,057 | $334.0K | 0.00% | +24,209+629.1% | Added |
| Bank of America Corp | 28,265 | $337.0K | 0.00% | +27,646+4,466.2% | Added |
| Charles Schwab Investment Management Inc | 60,594 | $722.0K | 0.00% | +41,172+212.0% | Added |
| Nuveen Asset Management, LLC | 36,879 | $731.0K | 0.00% | +16,916+84.7% | Added |
| Soleus Capital Management, L.P. | 64,585 | $769.0K | 0.10% | −498,811−88.5% | Reduced |
| Bank of New York Mellon Corp | 64,783 | $772.0K | 0.00% | +34,994+117.5% | Added |
| Caas Capital Management LP | 162,599 | $1.94M | 0.18% | 00.0% | Unchanged |
| Migdal Insurance & Financial Holdings Ltd. | 187,500 | $2.23M | 0.02% | 00.0% | Unchanged |
| Northern Trust Corp | 200,065 | $2.38M | 0.00% | +129,661+184.2% | Added |
| Alyeska Investment Group, L.P. | 206,201 | $2.46M | 0.03% | 00.0% | Unchanged |
| Platinum Investment Management Ltd | 213,381 | $2.54M | 0.07% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 214,224 | $2.55M | 0.00% | +77,752+57.0% | Added |
| State Street Corp | 259,626 | $3.09M | 0.00% | +143,562+123.7% | Added |
| FMR LLC | 370,734 | $4.42M | 0.00% | +132,234+55.4% | Added |
| PFM Health Sciences, LP | 400,000 | $4.76M | 0.17% | 00.0% | Unchanged |
| Avidity Partners Management LP | 485,000 | $5.78M | 0.12% | −140,120−22.4% | Reduced |
| Vanguard Group Inc | 527,545 | $6.28M | 0.00% | +357,280+209.8% | Added |
| DC Funds, LP | 580,902 | $6.92M | 40.97% | −8,200−1.4% | Reduced |
| Sphera Funds Management Ltd. | 648,391 | $7.72M | 0.92% | −40,084−5.8% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 958,125 | $11.4M | 0.24% | −794,662−45.3% | Reduced |
| Adage Capital Partners GP, L.L.C. | 960,448 | $11.4M | 0.02% | −25,000−2.5% | Reduced |
| BlackRock Inc. | 1,276,208 | $15.2M | 0.00% | +906,247+245.0% | Added |
| MPM Oncology Impact Management LP | 2,388,011 | $28.4M | 5.18% | 00.0% | Unchanged |
| MPM Asset Management LLC | 4,284,172 | $51.0M | 11.03% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 4,291,881 | $51.1M | 0.90% | 00.0% | Unchanged |
| Nicholas Investment Partners, LP | 0 | $0 | 0.00% | −296,283−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −125,873−100.0% | Sold out |
| Levin Capital Strategies, L.P. | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |